Treating Major Depression With Yoga Mono-therapy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, San Francisco

About this trial

The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to an education control intervention on holistic healthcare.

Eligibility criteria

Qualifiers

18 years of age or older

Able to give voluntary, informed consent

English-speaking

Diagnosis of clinical depression

Disqualifiers

Current use of antidepressant medication

Current engagement in psychotherapy

Current pregnancy

Significant medical issues interfering with yoga practice

Trial design

Treatments tested in this trial

  • Yoga practice
  • Education

Treatment groups

180 Participants
are divided into 2 treatment groups